CME Group Inc.
DE ˙ XTRA ˙ US12572Q1058
217,80 € ↑3,15 (1,47%)
2026-06-03
AKTIENPREIS
SecurityDE:MX4A / CME Group Inc.
InstitutionAPG Asset Management N.V.
Latest Disclosed Ownership234,686 shares
Latest Disclosed Value $ 60,158,401
APG Asset Management N.V. reports 3.19% decrease in ownership of MX4A / CME Group Inc.

On May 13, 2026 - APG Asset Management N.V. filed a 13F-HR form disclosing ownership of 234,686 shares of CME Group Inc. (DE:MX4A) valued at $59,950,539 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 242,415 shares of CME Group Inc.. This represents a change in shares of -3.19% during the quarter. The current value of the position is $51,114,611 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F CME GROUP COM 12572Q105 234,686 -7,729 -3.19 60,158 6.73 0.1906
2026-02-12 2025-12-31 13F CME GROUP COM 12572Q105 242,415 -18,650 -7.14 56,366 -6.11 0.1600
2025-11-12 2025-09-30 13F CME GROUP COM 12572Q105 261,065 -3,651 -1.38 60,032 -3.42 0.1685
2025-08-12 2025-06-30 13F CME GROUP COM 12572Q105 264,716 15,021 6.02 62,155 1.36 0.1840
2025-05-14 2025-03-31 13F CME GROUP COM 12572Q105 249,695 -222,715 -47.14 61,323 -42.12 0.1902
2025-02-13 2024-12-31 13F CME GROUP COM 12572Q105 472,410 341,238 260.15 105,947 308.54 0.2951
2024-11-14 2024-09-30 13F CME GROUP COM 12572Q105 131,172 -1,119,808 -89.51 25,934 -88.70 0.1721
2024-08-14 2024-06-30 13F CME GROUP COM 12572Q105 1,250,980 -42,368 -3.28 229,478 -10.99 0.4094
2024-05-14 2024-03-31 13F CME GROUP COM 12572Q105 1,293,348 6,921 0.54 257,819 5.12 0.4517
2024-02-13 2023-12-31 13F CME GROUP COM 12572Q105 1,286,427 100,506 8.47 245,256 3.29 0.4784
2023-11-14 2023-09-30 13F CME GROUP COM 12572Q105 1,185,921 -58,660 -4.71 237,445 12.33 0.4856
2023-08-14 2023-06-30 13F CME GROUP COM 12572Q105 1,244,581 10,444 0.85 211,373 -2.84 0.4263
2023-05-12 2023-03-31 13F CME GROUP COM 12572Q105 1,234,137 225,756 22.39 217,554 128,630.18 0.4616
2023-02-14 2022-12-31 13F CME GROUP COM 12572Q105 1,008,381 92,937 10.15 170 -99.90 0.3224
2022-11-14 2022-09-30 13F CME GROUP COM 12572Q105 915,444 -168,741 -15.56 165,521 -22.03 0.4270
2022-08-12 2022-06-30 13F CME GROUP COM 12572Q105 1,084,185 -157,463 -12.68 212,284 -20.02 0.4976
2022-05-12 2022-03-31 13F CME GROUP COM 12572Q105 1,241,648 -152,139 -10.92 265,437 -5.20 0.5016
2022-02-11 2021-12-31 13F CME GROUP COM 12572Q105 1,393,787 -119,987 -7.93 280,008 10.86 0.4757
2021-11-15 2021-09-30 13F/A-1 CME GROUP COM 12572Q105 1,513,774 -48,371 -3.10 252,585 -9.84 0.4489
2021-11-15 2021-09-30 13F CME GROUP COM 12572Q105 1,513,774 -48,371 252,585 0.4539
2021-08-13 2021-06-30 13F CME GROUP COM 12572Q105 1,562,145 -76,904 -4.69 280,156 -1.64 0.4758
2021-05-14 2021-03-31 13F CME GROUP COM 12572Q105 1,639,049 -64,934 -3.81 284,815 12.34 0.4861
2021-02-12 2020-12-31 13F CME GROUP COM 12572Q105 1,703,983 337,489 24.70 253,533 30.04 0.4135
2020-11-12 2020-09-30 13F CME GROUP COM 12572Q105 1,366,494 -41,331 -2.94 194,967 -4.31 0.3375
2020-08-14 2020-06-30 13F CME GROUP COM 12572Q105 1,407,825 13,100 0.94 203,738 -15.52 0.3713
2020-05-19 2020-03-31 13F/A-2 CME GROUP COM 12572Q105 1,394,725 -298,950 -17.65 241,162 -20.37 0.4727
2020-05-15 2020-03-31 13F/A-1 CME GROUP COM 12572Q105 1,394,725 0 241,162 0.4775
2020-05-14 2020-03-31 13F CME GROUP COM 12572Q105 1,493,756 -199,919 218,945 409,637.8662
2020-02-13 2019-12-31 13F CME GROUP COM 12572Q105 1,693,675 2,800 0.17 302,855 -7.61 0.4920
2019-11-08 2019-09-30 13F CME GROUP COM 12572Q105 1,690,875 102,619 6.46 327,783 21.08 0.5399
2019-08-13 2019-06-30 13F CME GROUP COM 12572Q105 1,588,256 94,500 6.33 270,720 23.65 0.4645
2019-05-14 2019-03-31 13F CME GROUP COM CL A 12572Q105 1,493,756 -53,900 -3.48 218,945 -14.03 0.4019
2019-02-19 2018-12-31 13F/A-1 CME GROUP COM CL A 12572Q105 1,547,656 -13,700 -0.88 254,687 11.31 0.5177
2019-02-13 2018-12-31 13F CME GROUP COM CL A 12572Q105 1,547,656 -13,700 254,687
2018-11-09 2018-09-30 13F CME GROUP COM CL A 12572Q105 1,561,356 3,000 0.19 228,806 4.58 0.4006
2018-08-13 2018-06-30 13F CME GROUP COM CL A 12572Q105 1,558,356 332,581 27.13 218,788 35.72 0.4021
2018-05-14 2018-03-31 13F CME GROUP COM CL A 12572Q105 1,225,775 144,570 13.37 161,204 22.58 0.3117
2018-02-21 2017-12-31 13F/A-1 CME GROUP COM CL A 12572Q105 1,081,205 -939,923 -46.50 131,504 -52.05 0.2406
2018-01-24 2017-12-31 13F CME GROUP COM CL A 12572Q105 1,081,205 -939,923 131,504
2017-10-19 2017-09-30 13F CME GROUP COM CL A 12572Q105 2,021,128 196,171 10.75 274,227 19.98 0.4516
2017-07-21 2017-06-30 13F CME GROUP COM 12572Q105 1,824,957 -74,766 -3.94 228,558 1.27 0.4151
2017-05-01 2017-03-31 13F CME GROUP COM 12572Q105 1,899,723 1,463,198 335.19 225,687 372.75 0.4136
2017-01-30 2016-12-31 13F CME GROUP COM 12572Q105 436,525 -1,098,784 -71.57 47,739 -70.25 0.0898
2016-10-31 2016-09-30 13F CME GROUP COM 12572Q105 1,535,309 246,379 19.12 160,470 27.82 0.2819
2016-08-11 2016-06-30 13F CME GROUP COM 12572Q105 1,288,930 257,777 25.00 125,542 26.76 0.2363
2016-05-16 2016-03-31 13F CME GROUP COM 12572Q105 1,031,153 -182,366 -15.03 99,042 -9.92 0.2055
2016-02-17 2015-12-31 13F/A-1 CME GROUP COM 12572Q105 1,213,519 -588,520 -32.66 109,945 -34.21 0.2532
2016-02-16 2015-12-31 13F CME GROUP COM 12572Q105 34,343 109,945
2015-11-12 2015-09-30 13F CME GROUP COM 12572Q105 1,802,039 -760,900 -29.69 167,121 -29.93 0.3827
2015-08-12 2015-06-30 13F CME GROUP COM 12572Q105 2,562,939 -135,816 -5.03 238,507 -6.69 0.4784
2015-05-14 2015-03-31 13F CME GROUP COM 12572Q105 2,698,755 63,801 2.42 255,599 9.42 0.5284
2015-02-09 2014-12-31 13F CME GROUP COM 12572Q105 2,634,954 327,482 14.19 233,589 26.61 0.4478
2014-11-12 2014-09-30 13F CME GROUP COM 12572Q105 2,307,472 527,030 29.60 184,494 46.05 0.3730
2014-08-11 2014-06-30 13F CME GROUP COM 12572Q105 1,780,442 512,190 40.39 126,322 34.58 0.2697
2014-04-30 2014-03-31 13F CME GROUP COM 12572Q105 1,268,252 0 0.00 93,863 -5.67 0.2452
2014-02-20 2013-12-31 13F/A-1 CME GROUP COM 12572Q105 1,268,252 -7,689 -0.60 99,507 5.56 0.2925
2014-02-12 2013-12-31 13F CME GROUP COM 12572Q105 1,268,252 99,507
2013-11-13 2013-09-30 13F CME GROUP COM 12572Q105 1,275,941 -120,562 -8.63 94,267 -11.16 0.2978
2013-08-14 2013-06-30 13F CME GROUP COM 12572Q105 1,396,503 1,396,503 106,106 0.3312
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.